Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections

NCT05509413 is registered in ClinicalTrials.gov with Ruhr University of Bochum as lead sponsor.

NCT NCT05509413
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05509413 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DEFLAGYN® Vaginal Gel and Spontaneous Remission and Regression of Unclear Cervical Smears and HPV High-risk Infections
Lead sponsor
Ruhr University of Bochum
Phase
Not applicable
Overall status
Completed
Start date
November 8, 2022
Completion date
August 28, 2025
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervix dysplasia, hpv infection